Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

referredUnited States· United States Congress· EN

Introduced

6 May 2008

Last action

—

Status

Referred to the Subcommittee on Health.

Summary

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

Introduced in House (text)

View file Download file

Introduced in House (text)
Introduced in House · EN · 6 May 2008
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 6 May 2008
View Download Open at official source
Introduced in House
summary · EN · 6 May 2008
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/110th-congress/house-concurrent-resolution/342
Open data entity: https://api.congress.gov/v3/bill/110/hconres/342